JUL 17, 2026 · REGULATORY LABEL UPDATE
FDA supplemental approval: Dexamethasone Sodium Phosphate (Labeling)
U.S. Food and Drug Administration
FDA supplemental approval of dexamethasone sodium phosphate labeling; describes regulatory action only, not clinical evidence or efficacy.
Reported
Approval date2026-07-17
Formulation strength10 mg/mL